The Wolverine Stack: BPC-157 and TB-500 Research Profile
A research-grade combination of two peptides studied for connective-tissue research models, angiogenesis pathways, and in vitro repair mechanisms. Peer-reviewed mechanism. Third-party HPLC-tested. COAs on every batch.
Shop BPC-157 | Shop TB-500 | Read Peer-Reviewed Citations
TL;DR. “Wolverine Stack” is an informal research-community term for studying BPC-157 and TB-500 together. Improved Peptides does not sell a Wolverine Stack blend, kit, combo, bundle, or stack product. This page is an informational research comparison only. BPC-157 and TB-500 are available individually as research peptides with third-party COAs. Research use only.
What is the Wolverine Stack?
The “Wolverine Stack” is the informal research community name for the combined administration of two synthetic peptides:
- BPC-157 — a 15-amino-acid pentadecapeptide derived from a partial sequence of body protection compound, originally isolated from human gastric juice
- TB-500 — a synthetic fragment (residues 17-23) of the naturally occurring 43-amino-acid protein Thymosin Beta-4
The name references the X-Men character — popularized in research-community shorthand — a popular metaphor in the research community because both peptides have been studied for their respective roles in soft-tissue repair, angiogenesis, and connective-tissue research pathways.
Important: Improved Peptides sells BPC-157 and TB-500 strictly for laboratory and in vitro research use. We do not provide dosing protocols, human-use guidance, or clinical recommendations. Researchers should consult peer-reviewed literature for dosing references.
Why are they studied together?
The two peptides act on complementary tissue-repair pathways:
| Peptide | Primary studied mechanism | Tissue affinity |
|---|---|---|
| BPC-157 | Modulation of nitric oxide system, VEGFR2-mediated angiogenesis, gut-brain axis stabilization | Gut, tendon, ligament, gastric mucosa |
| TB-500 | Actin sequestration, cell migration, anti-inflammatory, angiogenesis | Muscle, cardiac tissue, cornea, skin |
Animal model studies have examined each compound independently for:
- BPC-157: Achilles tendon repair, gut healing, skin wound closure (Sikiric et al., 2016, 2020)
- TB-500: Cardiac repair, dermal wound healing, corneal regeneration (Goldstein et al., 2012; Bock-Marquette et al., 2004)
The research community hypothesizes — but does not yet have published combined-administration human studies — that the two peptides may have additive or synergistic effects on connective-tissue repair. No combined-protocol clinical trials have been published as of April 2026.
Mechanism summary
BPC-157 mechanism (selected published research)
- Angiogenesis: Promotes VEGFR2-mediated endothelial cell migration (Hsieh et al., 2017)
- Nitric oxide system: Modulates eNOS expression in injured tissue (Sikiric et al., 2020)
- Gut-brain axis: Stabilizes the dopaminergic and serotonergic systems following gut injury (Sikiric et al., 2016)
- Tendon-to-bone healing: Accelerates connective-tissue repair in rat models (Krivic et al., 2006)
TB-500 mechanism (selected published research)
- Actin regulation: Sequesters G-actin monomers, regulating cytoskeletal dynamics (Goldstein et al., 2012)
- Cell migration: Promotes endothelial and stem-cell migration into injured zones (Malinda et al., 1999)
- Cardiac repair: Reactivates epicardial progenitor cells in adult cardiac tissue (Bock-Marquette et al., 2004)
- Anti-inflammatory: Downregulates pro-inflammatory cytokines in dermal wound models (Sosne et al., 2010)
Citations (peer-reviewed, PubMed-linked)
BPC-157
- Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157 in cytoprotection.” Pharmacol Rep. 2020. PMID: 31158953
- Sikiric P, et al. “Brain-gut axis and pentadecapeptide BPC 157.” Curr Neuropharmacol. 2016. PMID: 27138887
- Chang CH, et al. “BPC 157 activates the FAK-paxillin pathway in tendon repair.” J Orthop Res. 2011. PMID: 21030672
- Krivic A, et al. “Pentadecapeptide BPC 157 in transected Achilles tendon.” J Orthop Res. 2006. PMID: 16575901
- Hsieh MJ, et al. “BPC 157 enhances angiogenesis via VEGFR2.” J Mol Med. 2017. PMID: 27847966
- Seiwerth S, et al. “BPC 157 and standard angiogenic growth factors.” Curr Pharm Des. 2014. PMID: 23782145
TB-500 (Thymosin Beta-4)
- Goldstein AL, et al. “Thymosin beta-4: tissue-repair properties.” Ann N Y Acad Sci. 2012. PMID: 22074294
- Crockford D, et al. “Thymosin beta-4 in clinical trials for chronic wounds.” Ann N Y Acad Sci. 2010. PMID: 20536467
- Bock-Marquette I, et al. “Thymosin beta-4 activates cardiac repair.” Nature. 2004. PMID: 15565145
- Sosne G, et al. “Thymosin beta-4 in corneal wound healing.” Ann N Y Acad Sci. 2010. PMID: 20179146
- Malinda KM, et al. “Thymosin beta-4 stimulates directional migration.” FASEB J. 1999. PMID: 10469335
- Philp D, et al. “Thymosin beta-4 promotes dermal wound healing.” Wound Repair Regen. 2004. PMID: 15037014
Quality and verification
Every batch of our BPC-157 and TB-500 is independently tested by a third-party laboratory using:
- HPLC — for purity (target 99%+)
- Mass spectrometry — for sequence confirmation
- UV spectroscopy — for concentration verification
Current batch COAs are published in our COA Library and linked from each product page. Every lot is traceable.
Storage and reconstitution (research reference)
| Stage | Condition |
|---|---|
| Lyophilized vial (shipping) | Room temperature, stable for 2-3 weeks |
| Lyophilized vial (long-term) | Refrigerator (2-8°C) for 6-12 months; freezer (-20°C) for 24+ months |
| Reconstituted (with bacteriostatic water) | Refrigerated, use within 28 days |
Reconstitution solvent: Bacteriostatic water with 0.9% benzyl alcohol. Available at bacteriostatic water.
FAQ
What is the Wolverine Stack?
An informal research community term for the combined study of BPC-157 and TB-500, two synthetic peptides examined for complementary roles in tissue repair.
Are BPC-157 and TB-500 commonly studied together?
Yes. Although there are no published combined-protocol clinical trials, the two peptides are frequently discussed together because their mechanisms target complementary tissue-repair pathways.
Where do I find peer-reviewed citations?
Citations are listed in the section above, each with a direct PubMed link. We update the citation list as new peer-reviewed research is published.
What purity standard does Improved Peptides verify?
HPLC-tested 99%+ purity, sequence-confirmed by mass spectrometry, with a COA from an independent third-party lab on every batch.
Are these peptides available for research use?
All compounds offered by Improved Peptides are sold strictly for in vitro and laboratory research use. They are not for human consumption, diagnosis, or treatment.
Ready to source the Wolverine Stack?
Both BPC-157 and TB-500 are stocked, HPLC-tested, and ship same-day on orders before 2pm ET.